J Frontier Co Ltd
TSE:2934
Intrinsic Value
J Frontier Co., Ltd. engages in the sale, manufacture, planning, and development of healthcare products. [ Read More ]
The intrinsic value of one J Frontier Co Ltd stock under the Base Case scenario is 3 033.43 JPY. Compared to the current market price of 2 489 JPY, J Frontier Co Ltd is Undervalued by 18%.
Valuation Backtest
J Frontier Co Ltd
Run backtest to discover the historical profit from buying and selling J Frontier Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
J Frontier Co Ltd
Current Assets | 5.4B |
Cash & Short-Term Investments | 1.2B |
Receivables | 2.2B |
Other Current Assets | 2B |
Non-Current Assets | 3.3B |
PP&E | 337.3m |
Intangibles | 2.3B |
Other Non-Current Assets | 683.2m |
Current Liabilities | 3.9B |
Accounts Payable | 1.3B |
Accrued Liabilities | 222.2m |
Short-Term Debt | 696.6m |
Other Current Liabilities | 1.6B |
Non-Current Liabilities | 2B |
Long-Term Debt | 1.6B |
Other Non-Current Liabilities | 370.7m |
Earnings Waterfall
J Frontier Co Ltd
Revenue
|
17B
JPY
|
Cost of Revenue
|
-9.1B
JPY
|
Gross Profit
|
7.9B
JPY
|
Operating Expenses
|
-9.4B
JPY
|
Operating Income
|
-1.5B
JPY
|
Other Expenses
|
-253.3m
JPY
|
Net Income
|
-1.7B
JPY
|
Free Cash Flow Analysis
J Frontier Co Ltd
Profitability Score
Profitability Due Diligence
J Frontier Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
J Frontier Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
J Frontier Co Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
J Frontier Co Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
J Frontier Co Ltd
Shareholder Return
Price
J Frontier Co Ltd
Average Annual Return | 0.64% |
Standard Deviation of Annual Returns | 62.15% |
Max Drawdown | -62% |
Market Capitalization | 12.3B JPY |
Shares Outstanding | 4 933 890 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
J Frontier Co., Ltd. engages in the sale, manufacture, planning, and development of healthcare products. The company is headquartered in Shibuya-Ku, Tokyo-To. The company went IPO on 2021-08-27. The firm operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.
Contact
IPO
Employees
Officers
The intrinsic value of one J Frontier Co Ltd stock under the Base Case scenario is 3 033.43 JPY.
Compared to the current market price of 2 489 JPY, J Frontier Co Ltd is Undervalued by 18%.